https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-03-29 / Oncol. Rep. 2011 Jun;25(6):1573-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-03-29 / Oncol. Rep. 2011 Jun;25(6):1573-92011-03-29 00:00:002011-03-29 00:00:00Effect of hyperthermia on invasion ability and TGF-β1 expression of breast carcinoma MCF-7 cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-03-25 / Eur. J. Cell Biol. 2012 Jan;91(1):53-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-03-25 / Eur. J. Cell Biol. 2012 Jan;91(1):53-82011-03-25 00:00:002019-02-15 08:40:02Third generation dendritic cell vaccines for tumor immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-292011-03-17 00:00:002021-11-15 16:59:03Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-03-02 / Cancer Immunol. Immunother. 2011 Jun;60(6):809-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-03-02 / Cancer Immunol. Immunother. 2011 Jun;60(6):809-182011-03-02 00:00:002019-02-15 08:40:07hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-03-01 / Scand. J. Immunol. 2011 Mar;73(3):222-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-03-01 / Scand. J. Immunol. 2011 Mar;73(3):222-332011-03-01 00:00:002019-02-15 08:49:20Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2
